Trials / Conditions / Mycosis Fungoides/Sezary Syndrome

Mycosis Fungoides/Sezary Syndrome

8 registered clinical trials studyying Mycosis Fungoides/Sezary Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Res NCT06651203	Assistance Publique - Hôpitaux de Paris	—
Active Not Recruiting	Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome NCT05944562	Washington University School of Medicine	Phase 1
Active Not Recruiting	Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome NCT04960618	Memorial Sloan Kettering Cancer Center	Phase 2
Withdrawn	Study of Photopheresis in the Treatment of Erythrodermic MF and SS NCT03563040	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Active Not Recruiting	IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma NCT03902184	Innate Pharma	Phase 2
Active Not Recruiting	A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory NCT03385226	University College, London	Phase 2
Terminated	PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) NCT03357224	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Completed	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015	Wake Forest University Health Sciences	Phase 1